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Table. Coeffi cients of Variation (CV) for the 10 Allergens Detected by 
the Control Serum KS11 in the ISAC CRD 103 Microarray for Intraslide, 
Intra-Assay, and Interassay Variability Assessment
  
     Control Intraslide Intra-assay Inter-assay
 Serum (KS11) CV, % CV, % CV, %
rApi g 1 21 27 44
rBet v 2 7 12 32
nBos d 4 10 8 20
nGal d 1 9 39 39
nGal d 2 4 11 36
Gal d 3 117 130 51
Hev b 8 7 19 31
Phl p 5 7 10 23
Phl p 6 23 28 33
Phl p 7 3 9 26
Specifi c immunoglobulin (Ig) E determination against 
allergens using the in vitro component-resolved diagnostic 
microarray technique (ImmunoCap ISAC CRD 103; Phadia, 
Uppsala, Sweden), has improved diagnostic accuracy [1-4], 
but few studies have analyzed the reproducibility of this semi-
quantitative technique [5]. 
Reproducibility is analyzed in successive determinations 
carried out using the KS11 control serum provided with 
the test kit. This serum contains different concentrations of 
specifi c IgE against 10 allergens: rApi g 1, rBet v 2, nBos d 
4, nGal d 1, nGal d 2, nGal d 3, rHev b 8, rPhl p 5, rPhl p 6, 
and rPhl p 7. The resulting data are then used to generate a 
standard curve that relates the fl uorescence signal of the ISAC 
CRD103 microarray acquired by a laser scanner (LuxScan 
10K/A, CapitalBio, Beijing, China) to known concentrations 
of specifi c IgE measured in ISAC standardized units (ISUs).
The microarray assay was performed according to the 
manufacturer´s instructions. The KS11 serum was analyzed for 
intraslide variability (4 times), intra-assay variability (8 times), 
and interassay variability (12 times). The reproducibility of the 
technique was analyzed by calculating the intraclass correlation 
coeffi cient (ICC) for overall variability using the software 
package SPSS 15.0 and the coeffi cient of variation (CV) for the 
variability of each of the 10 allergens using Microsoft Excel 97.
According to the classifi cation of Fleiss [6], the ICCs were 
almost perfect for all 3 tests, with a score of 0.998 for intraslide 
variability (P<.0001), of 0.997 for intra-assay variability 
(P<.0001), and of 0.989 for interassay variability (P<.0001).
For the intraslide analysis, 7 of the 10 allergens detected 
by KS11 had CV values of 10% or less, and for the intra-assay 
analysis, 5 allergens had CV values of 15% or less. In the 
interassay analysis, all of the allergens had CV values of over 
20%, three allergens (nBos d 4, rPhl p 5, and rPhl p 6) had 
values of between 20% and 30%, while 5 (rBet v 2, nGal d 1, 
nGal d 2, rHev b 8, and rPhl p 6) had values of under 40%. 
The remaining 2 allergens, rApi g 1 and nGal d 3, had values 
of 44% and 51%, respectively (Table). 
While excellent results were observed for overall intraslide, 
intra-assay, and interassay variability, rApi g 1, nGal d 3, and 
rPhl p 6 all showed high variability in the individual analyses. 
Jahn-Schmid et al [5] reported similar results for rPhi p6. 
Moreover, in our study, nGal d3 had the highest CV. This 
suggests the existence of a technical problem related to the 
adhesion of the allergen to the slide, highlighting the need to 
validate each allergen individually. This requirement should 
be even stricter for allergens used to establish the standard 
curve, and to defi ne specifi c IgE levels for all the allergens in 
the ISAC CRD 103 microarray.
Moreover, the fact that the variability of the data in 
the interassay analysis can be improved suggests that this 
technique can be used to assess sensitization profi les but is 
not appropriate for monitoring sensitization.
On the basis of our results, it can be concluded that, overall, 
the semi-quantitative ISAC CDR 103 method is a reproducible 
technique. However, the high variability detected for certain 
allergens suggests that this in vitro tool is valid for an initial 
study but probably not for follow-up or monitoring studies, 
or for establishing therapeutic decisions. In such cases, we 
recommend the use of quantitative tests such as specifi c IgE 
determination.
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In a recent report of selective hypersensitivity to nimesulide 
with urticarial reactions [1], skin tests (skin prick testing [SPT] 
and intradermal testing [IDT]) with nimesulide and Sepharose-
radioimmunoassay were unable to demonstrate the existence 
of an immunoglobulin (Ig) E–dependent mechanism. 
In July 2008, a 44-year-old man with a history of mild allergic 
rhinitis and documented sensitivity to Dermatophagoides 
species consulted for systemic urticaria in January and urticaria 
with acute diarrhea in April. Both reactions had appeared 
within 15 minutes of taking a 100-mg tablet of nimesulide 
for a headache. The patient had taken these tablets at least 10 
times in the previous 2 years, without adverse reactions. The 
symptoms disappeared spontaneously within 40 minutes, and 
the patient had since tolerated diclofenac and acetylsalicylic 
acid (ASA). 
The patient and 3 healthy nonatopic individuals, who 
usually tolerated nimesulide, underwent parallel SPT with 1, 
5, 10, and 20 mg/mL concentrations of nimesulide in distilled 
water. The tests were negative in the controls but induced a 
positive skin response with a dose-related wheal-and-fl are 
reaction in the patient (Figure 1A). 
The patient agreed to undergo a series of single-blind 
placebo-controlled oral provocation tests (OPTs), 1 week apart, 
with increasing doses of nimesulide, celecoxib, and ASA. 
Under controlled clinical conditions, the OPTs were performed 
by administering, at 90-minute intervals, 2 consecutive placebo 
doses (talc) followed by the drugs at a dose of l:100, 1:20, 
1:10, and 1:3, and fi nally at the remainder of the therapeutic 
dose. ASA and celecoxib did not induce any adverse clinical 
reactions, but the nimesulide OPT was stopped after the 
second dose because the patient experienced diffuse urticaria, 
vomiting, and an associated 25% decrease in basal systolic 
blood pressure after 10 minutes. Intramuscular epinephrine 
1 mg, intramuscular chlorpheniramine, and intravenous 
methylprednisolone were administered, and the symptoms 
resolved within 40 minutes.
In March 2009, according to Empedrad et al [2], we 
carried out an in vivo skin test study in 30 healthy volunteers, 
all regular users of nimesulide with no adverse reactions, to 
identify the highest concentrations of nimesulide that did not 
produce skin irritation. Due to the poor solubility of nimesulide 
in water (0.014 mg/mL), we performed the tests with a 
solution of nimesulide (Fingrange-Pharma, London, UK) in 
polyethylene-glycol 400 (PEG 400; ST-Trading- LLC, New 
York, USA), a semi-polar solvent with an optimal solubility 
of 63.120 mg/mL for nimesulide [3]. 
The nonirritating concentrations of nimesulide-PEG 400 
solutions were identifi ed as 20 mg/mL for SPT and 1 mg/mL 
for IDT. We then retested our patient with nimesulide- PEG 
400 solutions at increasing concentrations and the previously 
effective nimesulide-water solutions. Of interest, in the case of 
the nimesulide-water solution, only IDT at a concentration of 
20 mg/mL was positive. In the case of the PEG 400 solution, 
SPT was positive only at a concentration of 20 mg/mL, 
whereas IDT was positive from 0.2 mg/mL upwards; there 
was, however, no increase in the wheal-and-fl are reaction 
with increasing concentrations of the drug up to the maximum 
nonirritating dose (Figure 1B).
In October 2009, skin tests performed with the nimesulide-
water and nimesulide-PEG 400 solutions were negative. 
The spontaneous modulation of skin reactivity observed in 
the patient suggests that skin tests for nimesulide should be 
performed early because specifi c skin sensitivity to this drug 
seems to decrease quickly after the adverse drug reaction, in 
a similar manner to that reported for ß-lactam antibiotics [4]. 
The positive skin tests using nonirritating concentrations of 
nimesulide and the selective OPT strongly suggest a selective 
allergic hypersensitivity to nimesulide.
